NLRP7 Protein — NLR Family Pyrin Domain Containing 7

NLRP7 Protein — NLR Family Pyrin Domain Containing 7

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">NLRP7 Protein — NLR Family Pyrin Domain Containing 7</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>NLRP7</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[NLRP7](/genes/nlrp7)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>[Q8WX94](https://www.uniprot.org/uniprot/Q8WX94)</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~106 kDa (871 amino acids)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cytoplasm, Cytosol</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>NLR family, NOD-like receptor family</td>
</tr>
<tr>
<td class="label">Domain</td>
<td>Position</td>
</tr>
<tr>
<td class="label">Pyrin Domain (PYD)</td>
<td>1-92 aa</td>
</tr>
<tr>
<td class="label">NACHT Domain</td>
<td>230-405 aa</td>
</tr>
<tr>
<td class="label">LRR Domain</td>
<td>612-770 aa</td>
</tr>
<tr>
<td class="label">Tissue</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Testis</td>
<td>High</td>
</tr>
<tr>
<td class="label">Ovary</td>
<td>High</td>
</tr>
<tr>
<td class="label">Placenta</td>
<td>High</td>
</tr>
<tr>
<td class="label">Immune tissues (spleen, lymph nodes)</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Brain</td>
<td>Low to moderate</td>
</tr>
<tr>
<td clas

NLRP7 Protein — NLR Family Pyrin Domain Containing 7

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">NLRP7 Protein — NLR Family Pyrin Domain Containing 7</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>NLRP7</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[NLRP7](/genes/nlrp7)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>[Q8WX94](https://www.uniprot.org/uniprot/Q8WX94)</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~106 kDa (871 amino acids)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cytoplasm, Cytosol</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>NLR family, NOD-like receptor family</td>
</tr>
<tr>
<td class="label">Domain</td>
<td>Position</td>
</tr>
<tr>
<td class="label">Pyrin Domain (PYD)</td>
<td>1-92 aa</td>
</tr>
<tr>
<td class="label">NACHT Domain</td>
<td>230-405 aa</td>
</tr>
<tr>
<td class="label">LRR Domain</td>
<td>612-770 aa</td>
</tr>
<tr>
<td class="label">Tissue</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Testis</td>
<td>High</td>
</tr>
<tr>
<td class="label">Ovary</td>
<td>High</td>
</tr>
<tr>
<td class="label">Placenta</td>
<td>High</td>
</tr>
<tr>
<td class="label">Immune tissues (spleen, lymph nodes)</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Brain</td>
<td>Low to moderate</td>
</tr>
<tr>
<td class="label">Peripheral blood mononuclear cells</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Approach</td>
</tr>
<tr>
<td class="label">Small Molecule Inhibitors</td>
<td>Target NACHT domain ATPase activity</td>
</tr>
<tr>
<td class="label">Anti-inflammatory Therapy</td>
<td>Downstream cytokine blockade</td>
</tr>
<tr>
<td class="label">Gene Therapy</td>
<td>CRISPR-based approaches</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/autoimmune" style="color:#ef9a9a">Autoimmune</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">20 edges</a></td>
</tr>
</table>

NLRP7 (NLR family pyrin domain containing 7) is a member of the NOD-like receptor (NLR) protein family that plays critical roles in innate immunity and inflammatory signaling. Originally characterized for its involvement in reproductive biology, particularly in recurrent hydatidiform mole, emerging evidence suggests NLRP7 may contribute to neuroinflammatory processes in the central nervous system. This page provides comprehensive information about NLRP7 structure, function, and its potential role in neurodegenerative diseases.

:: infobox .infobox-protein
::

Overview

NLRP7 is a member of the NLR family of pattern recognition receptors (PRRs) that participates in innate immune responses. Unlike its well-characterized relative [NLRP3](/proteins/nlrp3-protein), which is one of the most studied inflammasome sensors, NLRP7 has a distinct expression pattern and functional properties. The protein contains the characteristic NLR domain architecture: an N-terminal pyrin domain (PYD), a central NACHT domain, and C-terminal leucine-rich repeats (LRRs). While NLRP7 is expressed in various immune cell types including macrophages, monocytes, and dendritic cells, its expression in brain resident immune cells such as microglia remains an area of active investigation.

Structure

Domain Architecture

The NLRP7 protein (871 amino acids) contains three major functional domains:

Structural Features

• PYD Domain: The N-terminal pyrin domain adopts a six-helix bundle structure typical of death domain folds, enabling homotypic protein interactions required for inflammasome nucleation.
• NACHT Domain: The NACHT (NAIP, CIITA, HET-E, TP1) domain is the central effector module that undergoes ATP-dependent conformational changes during activation. The NACHT domain of NLRP7 shares structural homology with other NLR proteins but exhibits unique nucleotide-binding properties.
• LRR Domain: The leucine-rich repeat domain consists of multiple LRR motifs that mediate interactions with pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs).

Post-Translational Modifications

NLRP7 undergoes several post-translational modifications that regulate its activity:

• Phosphorylation: Key phosphorylation sites regulate NLRP7 oligomerization and inflammasome formation
• Ubiquitination: Subject to ubiquitin-mediated degradation controlling protein stability
• SUMOylation: Sumoylation can modify NLRP7 subcellular localization and interactions

Normal Function

Inflammasome Formation

NLRP7 can form inflammasome complexes that activate caspase-1, leading to the maturation of pro-inflammatory cytokines:

Immune Cell Regulation

NLRP7 functions in various immune cell types:

• Macrophages: Regulates inflammatory cytokine production in response to bacterial and viral pathogens
• Monocytes: Controls monocyte differentiation and inflammatory responses
• Dendritic Cells: Modulates antigen presentation and adaptive immune responses
• T Cells: Emerging evidence suggests NLRP7 may affect T cell function indirectly through cytokine modulation

Bacterial and Viral Sensing

NLRP7 recognizes various microbial components:

• Bacterial Toxins: Initial studies identified NLRP7 as a sensor for bacterial toxins, particularly those that disrupt membrane integrity
• Viral Components: Some evidence suggests NLRP7 can respond to viral infections
• Ligation Stress: May detect cellular distress signals during infection

Expression Pattern

Tissue Distribution

NLRP7 exhibits broad expression across tissues:

Cellular Distribution

• Immune Cells: Highest expression in macrophages, monocytes, and dendritic cells
• Brain: Expressed in microglia, astrocytes at lower levels
• Epithelial Cells: Present in various epithelial tissues

Role in Neurodegeneration

Neuroinflammation

While NLRP7 is primarily studied in reproductive and immune contexts, several lines of evidence suggest potential roles in neuroinflammation:

Microglial Expression: Microglia, the resident immune cells of the brain, express NLR family proteins. While NLRP3 is the best-characterized microglial NLR, NLRP7 may contribute to the overall inflammasome landscape in the brain.

Cytokine-Mediated Effects: NLRP7 inflammasome activation leads to IL-1β and IL-18 production, both of which are implicated in chronic neuroinflammation seen in AD and PD.

Blood-Brain Barrier: Peripheral NLRP7 activation may influence inflammatory signals that cross the blood-brain barrier, affecting brain immune responses.

Alzheimer's Disease

Potential connections between NLRP7 and AD pathophysiology:

• Inflammatory Milieu: The chronic neuroinflammatory environment in AD brain may involve multiple NLR proteins
• Amyloid Response: Some evidence suggests NLR inflammasomes can be activated by amyloid-beta aggregates
• Tau Pathology: Inflammatory signaling may contribute to tau hyperphosphorylation and spreading

Parkinson's Disease

Connections to PD include:

• Dopaminergic Neuron Vulnerability: Inflammation contributes to dopaminergic neuron death
• Alpha-Synuclein Aggregation: Inflammatory responses may be amplified by NLRP7-dependent mechanisms
• Microglial Activation: Chronic microglial activation is a hallmark of PD pathology

Amyotrophic Lateral Sclerosis (ALS)

NLRP7 may participate in the neuroinflammation observed in ALS:

• Motor Neuron Environment: Inflammatory processes contribute to motor neuron degeneration
• Glial Cell Activation: Astrocyte and microglial NLR proteins may modulate disease progression

Therapeutic Implications

Targeting NLRP7

Several therapeutic strategies are being explored:

Dual Targeting with NLRP3

Given the structural similarity between NLRP7 and NLRP3, some therapies may target multiple NLR proteins:

• Broad-spectrum NLR inhibitors affecting multiple NLR family members
• Combination approaches targeting upstream activation and downstream effects

Key Publications

See Also

• [NLRP7 Gene](/genes/nlrp7)
• [NLRP3 Protein](/proteins/nlrp3-protein) — related NLR family member
• [NLRP1 Protein](/proteins/nlrp1-protein) — NLR family member
• [Inflammasome Pathways](/mechanisms/inflammasome) — inflammasome mechanisms
• [Neuroinflammation](/cell-types/microglia-neuroinflammation) — microglia and brain inflammation
• [Alzheimer's Disease](/diseases/alzheimers-disease) — AD overview
• [Parkinson's Disease](/diseases/parkinsons-disease) — PD overview

External Links

• [NLRP7 UniProt Entry](https://www.uniprot.org/uniprot/Q8WX94)
• [NCBI Gene: NLRP7](https://www.ncbi.nlm.nih.gov/gene/92344)
• [PDB Structure](https://www.rcsb.org/structure/6N8H)

References